Correlation Between Bank of America and Dianthus Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank of America and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Dianthus Therapeutics, you can compare the effects of market volatilities on Bank of America and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Dianthus Therapeutics.

Diversification Opportunities for Bank of America and Dianthus Therapeutics

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bank and Dianthus is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Bank of America i.e., Bank of America and Dianthus Therapeutics go up and down completely randomly.

Pair Corralation between Bank of America and Dianthus Therapeutics

Considering the 90-day investment horizon Bank of America is expected to generate 0.52 times more return on investment than Dianthus Therapeutics. However, Bank of America is 1.93 times less risky than Dianthus Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Dianthus Therapeutics is currently generating about -0.26 per unit of risk. If you would invest  4,262  in Bank of America on August 27, 2024 and sell it today you would earn a total of  438.00  from holding Bank of America or generate 10.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bank of America  vs.  Dianthus Therapeutics

 Performance 
       Timeline  
Bank of America 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bank of America are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Bank of America exhibited solid returns over the last few months and may actually be approaching a breakup point.
Dianthus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Bank of America and Dianthus Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank of America and Dianthus Therapeutics

The main advantage of trading using opposite Bank of America and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.
The idea behind Bank of America and Dianthus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Stocks Directory
Find actively traded stocks across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account